398 related articles for article (PubMed ID: 26245651)
21. Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation.
Emdal KB; Pedersen AK; Bekker-Jensen DB; Tsafou KP; Horn H; Lindner S; Schulte JH; Eggert A; Jensen LJ; Francavilla C; Olsen JV
Sci Signal; 2015 Apr; 8(374):ra40. PubMed ID: 25921289
[TBL] [Abstract][Full Text] [Related]
22. Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.
Schulte JH; Schramm A; Klein-Hitpass L; Klenk M; Wessels H; Hauffa BP; Eils J; Eils R; Brodeur GM; Schweigerer L; Havers W; Eggert A
Oncogene; 2005 Jan; 24(1):165-77. PubMed ID: 15637590
[TBL] [Abstract][Full Text] [Related]
23. p75 mediated apoptosis in neuroblastoma cells is inhibited by expression of TrkA.
Eggert A; Sieverts H; Ikegaki N; Brodeur GM
Med Pediatr Oncol; 2000 Dec; 35(6):573-6. PubMed ID: 11107120
[TBL] [Abstract][Full Text] [Related]
24. The effect of P75 on Trk receptors in neuroblastomas.
Ho R; Minturn JE; Simpson AM; Iyer R; Light JE; Evans AE; Brodeur GM
Cancer Lett; 2011 Jun; 305(1):76-85. PubMed ID: 21419569
[TBL] [Abstract][Full Text] [Related]
25. Novel functional interactions between Trk kinase and p75 neurotrophin receptor in neuroblastoma cells.
Lachyankar MB; Condon PJ; Daou MC; De AK; Levine JB; Obermeier A; Ross AH
J Neurosci Res; 2003 Jan; 71(2):157-72. PubMed ID: 12503079
[TBL] [Abstract][Full Text] [Related]
26. Type I interferons up-regulate the expression and signalling of p75 NTR/TrkA receptor complex in differentiated human SH-SY5Y neuroblastoma cells.
Dedoni S; Olianas MC; Ingianni A; Onali P
Neuropharmacology; 2014 Apr; 79():321-34. PubMed ID: 24333329
[TBL] [Abstract][Full Text] [Related]
27. Cotransfection of TrkA and p75(NTR) in neuroblastoma cell line (IMR-32) promotes differentiation and apoptosis of tumor cells.
Chen J; Zhe X
Chin Med J (Engl); 2003 Jun; 116(6):906-12. PubMed ID: 12877805
[TBL] [Abstract][Full Text] [Related]
28. All-trans retinoic acid induces COX-2 and prostaglandin E2 synthesis in SH-SY5Y human neuroblastoma cells: involvement of retinoic acid receptors and extracellular-regulated kinase 1/2.
Alique M; Herrero JF; Lucio-Cazana FJ
J Neuroinflammation; 2007 Jan; 4():1. PubMed ID: 17204142
[TBL] [Abstract][Full Text] [Related]
29. Real time RT-PCR shows correlation between retinoid-induced apoptosis and NGF-R mRNA levels.
Vuillaume I; Schraen-Maschke S; Formstecher P; Sablonnière B
Biochem Biophys Res Commun; 2001 Dec; 289(3):647-52. PubMed ID: 11726196
[TBL] [Abstract][Full Text] [Related]
30. Low expression of human tubulin tyrosine ligase and suppressed tubulin tyrosination/detyrosination cycle are associated with impaired neuronal differentiation in neuroblastomas with poor prognosis.
Kato C; Miyazaki K; Nakagawa A; Ohira M; Nakamura Y; Ozaki T; Imai T; Nakagawara A
Int J Cancer; 2004 Nov; 112(3):365-75. PubMed ID: 15382060
[TBL] [Abstract][Full Text] [Related]
31. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
32. Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells.
Kim SN; Kim SG; Park SD; Cho-Chung YS; Hong SH
J Cell Physiol; 2000 Mar; 182(3):421-8. PubMed ID: 10653609
[TBL] [Abstract][Full Text] [Related]
33. Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer.
Wu X; Zhu Z; Li W; Fu X; Su D; Fu L; Zhang Z; Luo A; Sun X; Fu L; Dong JT
Breast Cancer Res; 2012 May; 14(3):R73. PubMed ID: 22569290
[TBL] [Abstract][Full Text] [Related]
34. Arsenic trioxide induces cell cycle arrest and affects Trk receptor expression in human neuroblastoma SK-N-SH cells.
Xiong X; Li Y; Liu L; Qi K; Zhang C; Chen Y; Fang J
Biol Res; 2018 Jun; 51(1):18. PubMed ID: 29898774
[TBL] [Abstract][Full Text] [Related]
35. Differences in gene expression profile among SH-SY5Y neuroblastoma subclones with different neurite outgrowth responses to nerve growth factor.
Oe T; Sasayama T; Nagashima T; Muramoto M; Yamazaki T; Morikawa N; Okitsu O; Nishimura S; Aoki T; Katayama Y; Kita Y
J Neurochem; 2005 Sep; 94(5):1264-76. PubMed ID: 15992370
[TBL] [Abstract][Full Text] [Related]
36.
Dzieran J; Rodriguez Garcia A; Westermark UK; Henley AB; Eyre Sánchez E; Träger C; Johansson HJ; Lehtiö J; Arsenian-Henriksson M
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1229-E1238. PubMed ID: 29374092
[TBL] [Abstract][Full Text] [Related]
37. Acidic substitution of the activation loop tyrosines in TrkA supports nerve growth factor-dependent, but not nerve growth factor-independent, differentiation and cell cycle arrest in the human neuroblastoma cell line, SY5Y.
Gryz EA; Meakin SO
Oncogene; 2003 Nov; 22(54):8774-85. PubMed ID: 14647472
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
[TBL] [Abstract][Full Text] [Related]
39. RET receptor expression and interaction with TRK receptors in neuroblastomas.
Tetri LH; Kolla V; Golden RL; Iyer R; Croucher JL; Choi JH; Macfarland SP; Naraparaju K; Guan P; Nguyen F; Gaonkar KS; Raman P; Brodeur GM
Oncol Rep; 2020 Jul; 44(1):263-272. PubMed ID: 32319659
[TBL] [Abstract][Full Text] [Related]
40. Expression of NTRK1/TrkA affects immunogenicity of neuroblastoma cells.
Pajtler KW; Rebmann V; Lindemann M; Schulte JH; Schulte S; Stauder M; Leuschner I; Schmid KW; Köhl U; Schramm A; Eggert A
Int J Cancer; 2013 Aug; 133(4):908-19. PubMed ID: 23400852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
